Azizi A - Search Results

1

An adjuvant-modulated vaccine response in human whole blood.

Hakimi J, Azizi A, Ausar SF, Todryk SM, Rahman N, Brookes RH. Hakimi J, et al. Among authors: azizi a. Hum Vaccin Immunother. 2017 Sep 2;13(9):2130-2134. doi: 10.1080/21645515.2017.1337616. Epub 2017 Jun 12. Hum Vaccin Immunother. 2017. PMID: 28605295 Free PMC article.

2

New approaches for characterization of the genetic stability of vaccine cell lines.

Ng S, Gisonni-Lex L, Azizi A. Ng S, et al. Among authors: azizi a. Hum Vaccin Immunother. 2017 Jul 3;13(7):1669-1672. doi: 10.1080/21645515.2017.1295191. Epub 2017 Feb 23. Hum Vaccin Immunother. 2017. PMID: 28333573 Free PMC article. Review.

3

Delivery of immunogens to mucosal immune system using an oral inactivated cholera vaccine: a new approach for development of oral vaccines.

Azizi A, Ghunaim H, Sirskyj D, Fallahi F, Le HT, Kumar A. Azizi A, et al. Hum Vaccin Immunother. 2013 Jul;9(7):1445-8. doi: 10.4161/hv.24200. Epub 2013 Mar 6. Hum Vaccin Immunother. 2013. PMID: 23466688

4

Advances and challenges in mucosal adjuvant technology.

Newsted D, Fallahi F, Golshani A, Azizi A. Newsted D, et al. Among authors: azizi a. Vaccine. 2015 May 15;33(21):2399-405. doi: 10.1016/j.vaccine.2015.03.096. Epub 2015 Apr 10. Vaccine. 2015. PMID: 25865473 Review.

5

Potency of cell-mediated immune responses to different combined HIV-1 immunogens in a humanized murine model.

Azizi A, Ghorbani M, Kryworuchko M, Aucoin S, Diaz-Mitoma F. Azizi A, et al. Hum Vaccin. 2005 Jul-Aug;1(4):170-6. doi: 10.4161/hv.1.4.1990. Epub 2005 Jul 5. Hum Vaccin. 2005. PMID: 17012859

6

Microbiota, a forgotten relic of vaccination.

Lex JR, Azizi A. Lex JR, et al. Among authors: azizi a. Expert Rev Vaccines. 2017 Dec;16(12):1171-1173. doi: 10.1080/14760584.2017.1393336. Epub 2017 Oct 25. Expert Rev Vaccines. 2017. PMID: 29050523 No abstract available.

7

In vitro assessment of biological activity and stability of the ALVAC-HIV vaccine.

Damjanovic D, He L, Symes J, Gajewska B, Azizi A, Salha D, Ettorre L, Bernardo-Reyes L, Su J, Phogat S, Gisonni-Lex L. Damjanovic D, et al. Among authors: azizi a. Vaccine. 2018 Sep 5;36(37):5636-5644. doi: 10.1016/j.vaccine.2018.07.034. Epub 2018 Aug 10. Vaccine. 2018. PMID: 30104115 Free article.

8

Evaluation of infectious titer in a candidate HSV type 2 vaccine by a quantitative molecular approach.

Azizi A, Tang M, Gisonni-Lex L, Mallet L. Azizi A, et al. BMC Microbiol. 2013 Dec 6;13:284. doi: 10.1186/1471-2180-13-284. BMC Microbiol. 2013. PMID: 24313978 Free PMC article.

9

Aggregation and Size Attributes Analysis of Unadsorbed and Adjuvant-adsorbed Antigens using a Multispectral Imaging Flow Cytometer Platform.

Choy CH, He L, Tulumello D, Gajewska B, Terebiznik MR, Botelho RJ, Azizi A. Choy CH, et al. Among authors: azizi a. J Pharm Sci. 2022 Mar;111(3):672-679. doi: 10.1016/j.xphs.2021.10.037. Epub 2021 Nov 3. J Pharm Sci. 2022. PMID: 34742727

10

Protective Efficacy of Candidate Vaccines Prior to Human Clinical Trials.

Azizi A. Azizi A. J Pharm Sci. 2018 Dec;107(12):2992-2994. doi: 10.1016/j.xphs.2018.08.005. Epub 2018 Aug 16. J Pharm Sci. 2018. PMID: 30121314

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

490 results

Search Page